Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
---|---|---|---|---|---|---|
LMST01020016 | CE(22:0) | Lipid-depleted/compactin | 0.0 | BCD100427B02 | 1.28 | pmol/sample |
LMST01020016 | CE(22:0) | Lipid-depleted/compactin | 0.5 | BCD100427B05 | 1.33 | pmol/sample |
LMST01020016 | CE(22:0) | Lipid-depleted/compactin | 1.0 | BCD100427B09 | 20.8 | pmol/sample |
LMST01020016 | CE(22:0) | Lipid-depleted/compactin | 2.0 | BCD100427B13 | 1.15 | pmol/sample |
LMST01020016 | CE(22:0) | Lipid-depleted/compactin | 4.0 | BCD100427B17 | 1 | pmol/sample |
LMST01020016 | CE(22:0) | Lipid-depleted/compactin | 8.0 | BCD100427B21 | - | pmol/sample |
LMST01020016 | CE(22:0) | Lipid-depleted/compactin | 12.0 | BCD100427B25 | - | pmol/sample |
LMST01020016 | CE(22:0) | Lipid-depleted/compactin | 24.0 | BCD100427B29 | - | pmol/sample |
LMST01020016 | CE(22:0) | C | 0.0 | BCD100427B01 | 3.73 | pmol/sample |
LMST01020016 | CE(22:0) | C | 0.5 | BCD100427B03 | 12.3 | pmol/sample |
LMST01020016 | CE(22:0) | C | 1.0 | BCD100427B07 | 10.9 | pmol/sample |
LMST01020016 | CE(22:0) | C | 2.0 | BCD100427B11 | 6.43 | pmol/sample |
LMST01020016 | CE(22:0) | C | 4.0 | BCD100427B15 | 10.4 | pmol/sample |
LMST01020016 | CE(22:0) | C | 8.0 | BCD100427B19 | 7.19 | pmol/sample |
LMST01020016 | CE(22:0) | C | 12.0 | BCD100427B23 | 40.4 | pmol/sample |
LMST01020016 | CE(22:0) | C | 24.0 | BCD100427B27 | 9.63 | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B06 | - | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B10 | - | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B14 | - | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B18 | 28.5 | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B22 | 1.2 | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B26 | 1.37 | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B30 | 1.9 | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol | 0.5 | BCD100427B04 | 6.14 | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol | 1.0 | BCD100427B08 | 11.3 | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol | 2.0 | BCD100427B12 | 5.88 | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol | 4.0 | BCD100427B16 | 0.51 | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol | 8.0 | BCD100427B20 | 9.46 | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol | 12.0 | BCD100427B24 | - | pmol/sample |
LMST01020016 | CE(22:0) | 25OH-Chol | 24.0 | BCD100427B28 | 12 | pmol/sample |